Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine

IMPORTANCE: Although 2 and 3 doses of vaccine have been implemented against the SARS-CoV-2 pandemic, the level of immunity achieved by these additional vaccinations remains unclear. OBJECTIVE: To investigate the induction of neutralizing antibodies against the SARS-CoV-2 Omicron variant after 2 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Koichi, Tjan, Lidya Handayani, Kurahashi, Yukiya, Sutandhio, Silvia, Nishimura, Mitsuhiro, Arii, Jun, Mori, Yasuko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086840/
https://www.ncbi.nlm.nih.gov/pubmed/35532938
http://dx.doi.org/10.1001/jamanetworkopen.2022.10780

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086840/
https://www.ncbi.nlm.nih.gov/pubmed/35532938
http://dx.doi.org/10.1001/jamanetworkopen.2022.10780

Ejemplares similares